04.01.21 Financial Times: How to vaccinate the world Share: Share on Linkedin Share on Twitter Share on Facebook GreenLight Biosciences is mentioned in the Financial Times looking at how to vaccinate the world. GreenLight Biosciences is mentioned in the Financial Times looking at how to vaccinate the world. The company is mentioned in relation to the potential of RNA for other uses in agriculture as well as vaccination programmes. An Extract is below: One day we could have mRNA-based vaccines for HIV, tuberculosis and cancer, says Ugur Sahin, co-founder of BioNTech and developer of Pfizer’s vaccine.RNA solutions could be used in agriculture instead of chemical pesticides, says GreenLight Biosciences. In fact, the potential of RNA is one reason why pharma companies are clinging to patents.They aren’t interested in making money from vaccinating Africa against Covid-19. They are playing a longer, bigger game. With HIV drugs, we wasted a fatal decade. Doing the right thing this time could spur global medicine into a new era. It wouldn’t even be particularly expensive. Read the full article here. Find out more about how GreenLight manufactures RNA here.